Companies

Dr Reddy’s heart drug generic in US

Our Bureau Hyderabad | Updated on January 17, 2018 Published on August 29, 2016

Pharma major Dr Reddy’s Laboratories has launched Nitroglycerin sublingual tablets, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets, in the US market. The drug indicated for preventing or relieving a sudden attack of angina (chest pain).

The Nitrostat (Nitroglycerin) sublingual tablet brand had the US sales of approximately $108 million MAT for the 12 months ending in March 2016 according to the IMS Health, said a release from the company. Dr Reddy’s scrip gained 0.28 per cent on the Bombay Stock Exchange on Monday to close at ₹3048.40.

Published on August 29, 2016
This article is closed for comments.
Please Email the Editor